Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$570K Sell
6,428
-83
-1% -$7.21K 0.27% 54
2026
Q1
$576K Sell
6,511
-399
-6% -$37.9K 0.3% 50
2025
Q4
$689K Sell
6,910
-33
-0.5% -$3.34K 0.34% 52
2025
Q3
$740K Sell
6,943
-37
-0.5% -$3.9K 0.37% 55
2025
Q2
$705K Sell
6,980
-175
-2% -$16.9K 0.38% 55
2025
Q1
$697K Hold
7,155
0.39% 55
2024
Q4
$729K Hold
7,155
0.39% 54
2024
Q3
$800K Sell
7,155
-33
-0.5% -$3.49K 0.4% 56
2024
Q2
$686K Sell
7,188
-238
-3% -$22.8K 0.37% 58
2024
Q1
$658K Sell
7,426
-16
-0.2% -$1.33K 0.34% 60
2023
Q4
$612K Buy
+7,442
New +$556K 0.33% 57

Other funds holding VLTO

Lipe & Dalton's VLTO Position: Q2 2026 in Review

Lipe & Dalton reduced its Veralto (VLTO) stake by 1.3% in Q2 2026, selling an estimated $7.21K and leaving 6,428 shares worth $570K. The position accounts for 0.27% of the portfolio, ranked #54.

Lipe & Dalton first reported a position in VLTO in Q4 2023 and has held it in 11 quarters since. The position peaked at $800K in Q3 2024. 377 funds tracked by Wall St. Rank hold VLTO as of Q2 2026.

  • Lipe & Dalton held 6,428 shares of Veralto worth $570K as of Q2 2026.
  • Lipe & Dalton sold 83 Veralto shares in Q2 2026, an estimated $7.21K.
  • Veralto made up 0.27% of Lipe & Dalton's portfolio in Q2 2026, its #54 holding.
  • Lipe & Dalton first reported a position in Veralto in Q4 2023 and has held it in 11 quarters since.
  • Lipe & Dalton's Veralto position peaked at $800K in Q3 2024.
  • 377 funds tracked by Wall St. Rank held Veralto as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.